what is her2 low in breast cancer?
Published 2 months ago • 50 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
5:16
treatment options for her2-low breast cancer: all you need to know
-
5:51
how brca, pdl1, and her2-low can affect a breast cancer diagnosis
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
1:36
is her2-low a distinct subtype of breast cancer?
-
7:13
overview of the management of her2-low breast cancer patients
-
2:13
remaining questions surrounding her2-low breast cancer – how low can you go?
-
11:12
her2-low breast cancer: destiny or good science?
-
2:31
male breast cancer survivor shares his story
-
1:40
her2-low is not a distinct subtype in inflammatory breast cancer
-
25:20
her2 low breast cancer a new therapeutic subtype | 2023 ku breast cancer year in review conference
-
54:43
the science of her2-low breast cancer and implications for the pathology team
-
0:46
biological behaviour of her2-low bc is dependent on hr expression
-
4:15
what is her2 testing in breast cancer? | dr kiley loh
-
1:33
questions remaining in the field of her2-low breast cancer
-
0:56
remaining questions on the management of her2-low breast cancer
-
0:32
highlights in her2-low breast cancer at sabcs 2022
-
30:27
advances in her2-positive and her2-low breast cancer
-
58:05
#breastpath destiny of her2/neu in the era of her2-low in 2024
-
1:20:02
her2-low expression in breast cancer: opportunities for expanding treatment benefit to more patients